You've probably heard that omega-3s are good for your health, but this is what you should know about the potential benefits and side effects.

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Study analyzing 77 research papers finds habitual consumption of processed foods increases chronic disease risk, challenging ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...